Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Daratumumab monotherapy in patients with treatment-refrac... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
0
Authors
Sagar Lonial
33 more
Sagar Lonial
•
Robert Vescio
31 more
•
Peter Voorhees
Published
January 7, 2016
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Hematology
Show all topics
DOI
10.1016/s0140-6736(15)01120-4
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Hematology
Show all topics
DOI
10.1016/s0140-6736(15)01120-4
Other Formats
PDF
